Skip to content

Medical-device intelligence

Ascensia Diabetes Care U.S., Inc.: FDA clearances and recalls

Research Ascensia Diabetes Care U.S., Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

7 clearance records and 0 recall records in the covered releases, across 1 source company names and 3 product codes. Dated history runs from Jun 24, 2016 to May 14, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

7 matching records
Device / recordCompany in FDA recordSourceSource date
MICROLET®NEXT 2 Lancing DeviceK250813 · QRLAscensia Diabetes Care U.S., Inc.510(k)May 14, 2025FDA decision date
CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose Monitoring SystemK241787 · NBWAscensia Diabetes Care U.S., Inc.510(k)Aug 27, 2024FDA decision date
MICROLET®NEXT LancetK241810 · QRKAscensia Diabetes Care U.S., Inc.510(k)Aug 15, 2024FDA decision date
CONTOUR® NEXT GEN Blood Glucose Monitoring SystemK223293 · NBWAscensia Diabetes Care U.S., Inc.510(k)Nov 18, 2022FDA decision date
MICROLET NEXT lancing device, MICROLET LancetK220633 · QRLAscensia Diabetes Care U.S., Inc.510(k)Jun 3, 2022FDA decision date
Contour Next EZ Blood Glucose Monitoring SystemK162336 · NBWAscensia Diabetes Care U.S., Inc.510(k)Jan 12, 2017FDA decision date
Contour Next Link Wireless Blood Glucose Monitoring System, Contour Next Blood Glucose Monitoring SystemK160430 · NBWAscensia Diabetes Care U.S., Inc.510(k)Jun 24, 2016FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗